Skip to main content
Back to Global Brain Corporation

Global Brain Corporation's Therapeutics Portfolio

Browse 10 Therapeutics companies funded by Global Brain Corporation. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
10
Total Funding in Therapeutics
$205.6M

Therapeutics Portfolio Companies (10)

Export
BiopharmaBiotechnologyClinical TrialsLife ScienceMedicalTherapeutics

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Emeryville, United States
September 2026
$44.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

ThinkCyte is a biotechnology company that provides sorting of cells for various applications in research, diagnostics, and therapeutics.

Hongo, Japan
August 2024
$14.8M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).

Bristol, United Kingdom
July 2023
Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.

Cambridge, United States
April 2026
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareNeuroscienceTherapeutics

Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.

Boston, United States
March 2026
$3.3M
Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Boston, United States
September 2024
$65.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyTherapeutics

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

San Carlos, United States
March 2024
$12.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalTherapeutics

Switch Therapeutics is a biotech company that develops RNAi therapies.

San Francisco, United States
March 2023
$52.0M
Series A

Founder Contacts

41,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.

Osaka, Japan
October 2024
$6.9M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

41,000+ verified contacts

Explore Global Brain Corporation's Full Portfolio

View all companies funded by Global Brain Corporation across every industry and funding stage.

View Full Global Brain Corporation Portfolio